Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
LISATA THERAPEUTICS, INC. (CLBS)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/11/2023 | Mazzo David J | CEO | Payment of Exercise | Common Stock | 1k | $3.20 | $3.3k | | 01/11/2023 |
| 01/10/2023 | Mazzo David J | CEO | Payment of Exercise | Common Stock | 3.5k | $3.20 | $11.1k | | 01/09/2023 |
| 01/10/2023 | Buck Kristen K | EVP, R&D and CMO | Payment of Exercise | Common Stock | 512 | $3.20 | $1.6k | | 01/09/2023 |
| 01/09/2023 | Buck Kristen K | EVP, R&D and CMO | Grant | Stock Options (Right to Buy) | 9k | $3.00 | $27k | | 01/09/2023 |
| 01/09/2023 | Buck Kristen K | EVP, R&D and CMO | Grant | Common Stock | 18k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | Buck Kristen K | EVP, R&D and CMO | Payment of Exercise | Common Stock | 2.1k | $3.00 | $6.4k | | 01/09/2023 |
| 01/09/2023 | Mazzo David J | CEO | Grant | Stock Options (Right to Buy) | 30k | $3.00 | $90k | | 01/09/2023 |
| 01/09/2023 | Flowers Cynthia Louise | Director | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | AZAB MOHAMMAD | Director | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | HENSON HEIDI | Director | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | BROWN GREGORY B | Director | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | Ruoslahti Erkki | Director | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | Mazzo David J | CEO | Payment of Exercise | Common Stock | 7.8k | $3.00 | $23.5k | | 01/09/2023 |
| 01/09/2023 | KLOSK STEVEN M | Director | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | Slack David W. | President & CBO | Grant | Common Stock | 24k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | Slack David W. | President & CBO | Payment of Exercise | Common Stock | 3.4k | $3.00 | $10.1k | | 01/09/2023 |
| 01/09/2023 | Slack David W. | President & CBO | Grant | Stock Options (Right to Buy) | 12k | $3.00 | $36k | | 01/09/2023 |
| 01/09/2023 | Mazzo David J | CEO | Grant | Common Stock | 60k | $0.00 | $0 | | 01/09/2023 |
| 09/15/2022 | AZAB MOHAMMAD | Director | Grant | Common Stock | 19.2k | $6.25 | $120k | | 09/15/2022 |
| 09/01/2022 | Buck Kristen K | EVP, R&D and CMO | Grant | Common Stock | 58k | $0.50 | $29k | | 09/01/2022 |
| 09/01/2022 | Buck Kristen K | EVP, R&D and CMO | Payment of Exercise | Common Stock | 25.2k | $0.50 | $12.6k | | 09/01/2022 |
| 09/01/2022 | Buck Kristen K | EVP, R&D and CMO | Payment of Exercise | Common Stock | 44.8k | $0.50 | $22.4k | | 09/01/2022 |
| 01/14/2022 | Mazzo David J | CEO | Payment of Exercise | Common Stock | 6.6k | $0.82 | $5.4k | | 01/13/2022 |
| 01/14/2022 | Girolamo Todd C | CLO, SVP of Corp Dev | Payment of Exercise | Common Stock | 2.2k | $0.82 | $1.8k | | 01/13/2022 |
| 01/13/2022 | Girolamo Todd C | CLO, SVP of Corp Dev | Payment of Exercise | Common Stock | 2.6k | $0.81 | $2.1k | | 01/13/2022 |
| 01/13/2022 | Mazzo David J | CEO | Payment of Exercise | Common Stock | 6.5k | $0.81 | $5.2k | | 01/13/2022 |
| 01/11/2022 | Mazzo David J | CEO | Payment of Exercise | Common Stock | 16.7k | $0.87 | $14.5k | | 01/10/2022 |
| 01/11/2022 | Girolamo Todd C | CLO, SVP of Corp Dev | Payment of Exercise | Common Stock | 4.7k | $0.87 | $4.1k | | 01/10/2022 |
| 01/10/2022 | Girolamo Todd C | CLO, SVP of Corp Dev | Grant | Stock Option (Right to Buy) | 65k | $0.92 | $59.6k | | 01/10/2022 |
| 01/10/2022 | Whitaker Anne Clem | Director | Grant | Common Stock | 65.4k | $0.00 | $0 | | 01/10/2022 |
| 01/10/2022 | Buck Kristen K | EVP, R&D and CMO | Grant | Common Stock | 64.5k | $0.00 | $0 | | 01/10/2022 |
| 01/10/2022 | Buck Kristen K | EVP, R&D and CMO | Payment of Exercise | Common Stock | 7.7k | $0.92 | $7.1k | | 01/10/2022 |
| 01/10/2022 | Buck Kristen K | EVP, R&D and CMO | Grant | Stock Option (Right to Buy) | 32.5k | $0.92 | $29.8k | | 01/10/2022 |
| 01/10/2022 | Girolamo Todd C | CLO, SVP of Corp Dev | Grant | Common Stock | 129k | $0.00 | $0 | | 01/10/2022 |
| 01/10/2022 | Girolamo Todd C | CLO, SVP of Corp Dev | Payment of Exercise | Common Stock | 17.4k | $0.92 | $16k | | 01/10/2022 |
|
|